NAV
$82.60
AUM
$10.9B
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.86
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +11.74% | +5.31% | +8.86% | +19.75% | +16.44% | +9.77% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 3.53% |
| 2 | AZN.L | AstraZeneca PLC | 2.01% |
| 3 | SIE.DE | Siemens AG | 1.76% |
| 4 | IFX.DE | Infineon Technologies AG | 1.49% |
| 5 | SHEL.L | Shell PLC | 1.48% |
| 6 | HSBA.L | HSBC Holdings PLC | 1.46% |
| 7 | NESN.SW | Nestle SA | 1.40% |
| 8 | ALV.DE | Allianz SE | 1.39% |
| 9 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.31% |
| 10 | BHP.AX | BHP Group Ltd | 1.27% |
Under normal circumstances, the fund invests at least 80% of its assets in equity securities. It seeks to outperform the MSCI EAFE Index over time while maintaining similar risk characteristics, including sector and geographic risks. In implementing its strategy, the fund primarily invests in securities included within the universe of the index. In addition, it may also invest in securities not included within the index. The fund only invests in the securities of companies located in developed markets.
Inception Date: 1992-10-28